| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.066 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.2 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.14 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |